---  
layout: startup_page  
title: "Diakonos Oncology"  
id: "diakonosoncology.com"  
permalink: "/diakonosoncologydiakonosoncology.com08262024/"  
website: "https://www.diakonosoncology.com/"  
funding_round: "Seed"  
funding_amount: "$11.4M"  
investors: "Restem Group Inc., existing investors"  
about: "Diakonos Oncology is a clinical-stage biotechnology company focused on revolutionizing cancer immunotherapy, particularly for difficult-to-treat cancers like glioblastoma. They develop dendritic cell vaccines (DCVs) using a proprietary double loading technology to initiate a complete cytotoxic T H 1 immune response against a patient's cancer. Their lead asset, DOC1021, is in Phase 2 clinical trials."  
markets: "Immuno-oncology, Cell Therapy, Drug Discovery, Biotechnology"  
hq: "Houston, Texas, United States"  
founded_year: "2016"  
linkedin: "https://www.linkedin.com/company/diakonos-oncology"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/diakonos-oncology?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase"  
pitchbook: "https://pitchbook.com/profiles/company/529306-30"  

date_display: "26-Aug-2024"  
date: "2024-08-26"

# SEO Optimization  
meta_title: "Diakonos Oncology - Seed Funding ($11.4M)"  
meta_description: "Diakonos Oncology, Diakonos Oncology is a clinical-stage biotechnology company focused on revolutionizing cancer immunotherapy, particularly for difficult-to-treat cance..."  
meta_keywords: "Diakonos Oncology, Immuno-oncology, Cell Therapy, Drug Discovery, Biotechnology, Seed funding"  
canonical_url: "https://startup.projectstartups.com/diakonosoncologydiakonosoncology.com08262024/"  
---